Status:
COMPLETED
Programmed Intermittent Bolus Infusion of Thoracic Paravertebral Block for Hepatectomy
Lead Sponsor:
Cui Xulei
Conditions:
Paravertebral Block
Hepatectomy
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Hepatectomy induces moderate to severe postoperative pain. Patient-controlled intravenous analgesia has been used in many medical centers for post-hepatectomy analgesia, but the effects are limited an...
Detailed Description
This study aims to compare the early postoperative morphine consumptions, pain scores, rescue analgesics, adverse effects and recovery indices, and the late postoperative life quality between patients...
Eligibility Criteria
Inclusion
- Age 18-70 yrs
- American Society of Anesthesiologists physical statusⅠ-Ⅲ
- Undergo hepatectomy with J-shape subcostal incision
- Informed consent
Exclusion
- A known allergy to the drugs being used
- Coagulopathy, on anticoagulants
- Analgesics intake, history of substance abuse
- Participating in the investigation of another experimental agent
- Unable to cooperate, eg. inability to properly describe postoperative pain to investigators
Key Trial Info
Start Date :
March 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2021
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT04304274
Start Date
March 10 2020
End Date
December 10 2021
Last Update
February 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, China